Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
99 participants
OBSERVATIONAL
2010-09-30
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cohort Study Comparing Short Daily Hemodialysis (HD) With Conventional HD
NCT00182156
Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis
NCT00732069
Effect of Nephral 400 ST Dialysis Membrane on Coagulation in Hemodialysis
NCT00594607
A Comparative Study of Two Kinds of Hemodialysis Filters
NCT05899283
Pilot Bleeding Study: Risk and Protective Factors Associated With Bleeding in the Hemodialysis Population
NCT00182117
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Myelodysplastic syndromes
* Baseline thrombocytopenia
* Acute infections (patients on antibiotics)
* Patients with Immune thrombocytopenic purpura (ITP)/Thrombotic thrombocytopenic purpura (TTP)
* HIV
* Liver disease
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Staten Island University Hospital
OTHER
Northwell Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Edward Epstein
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Edwerd Epstein, M.D.
Role: PRINCIPAL_INVESTIGATOR
Staten Island University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Island Rehabilitative Service
Staten Island, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-039
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.